Denmark· DK-28105940917

Ventizolve

A naloxone product containing naloxonhydrochlorid (vandfrit), registered in Denmark by Navamedic ASA. The same ATC class is registered in 11 of our 19 countries.

ATC V03AB15

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedVentizolveATCV03AB15REGISTER NO.DK-28105940917PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Naloxone is registered in 11 of 19 countries.

Countries holding a registration under ATC V03AB15 (naloxone), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 7 of them publish a price we can compare per daily dose

Naloxone · ATC V03AB15

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
NALOXONHYDROCHLORID (vandfrit)
Manufacturer
Navamedic ASA
Country
Denmark (DK)
ATC code
V03AB15
ATC class
Naloxone
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28105940917

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

104 interactions on record for naloxone.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Naloxone · interactions on record

104 records

  • 2 severe
  • 34 moderate
  • 4 minor
  • 64 info

Most severe, free to view

  • DroperidolN01AX01severe
  • DroperidolN05AD08severe
  • Methylnaltrexone bromideA06AH01moderate
  • NaloxegolA06AH03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/abdaa5b9-59d8-4283-9a87-81ed7e053415
GET /v1/drugs/abdaa5b9-59d8-4283-9a87-81ed7e053415?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "næsespray, opløsning i enkeltdosisbeholder",
  "source": "dkma",
  "strength": "1,26 mg/dosis",
  "auth_role": "CMS",
  "dk_drugid": "28105940917",
  "substance": "NALOXONHYDROCHLORID (vandfrit)",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "43362"
}

See everything about naloxone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.